Business
Southwest plane parked at gate
(Kevin Carter/Getty Images)
baggage

Southwest struggles with costs, pulls its 2025 outlook on tariff uncertainty

All the big four airlines have now reported first-quarter results, but none of them know what their futures will look like.

Max Knoblauch

Shares of Southwest Airlines slipped more than 3% premarket as the company posted a first-quarter loss and said its nonfuel costs were rising.

In its last full quarter with its famous “bags fly free” policy, Southwest reported revenue of $6.43 billion, above analyst estimates of $6.39 billion. The carrier posted a loss of $0.13 a share, better than the loss of $0.18 expected by analysts.

Despite a slew of cost-cutting measures since it ceded five board seats to activist investor Elliott Management in October, Southwest reported that its nonfuel costs rose 4.6% in the first quarter. The carrier expects those costs to rise between 3.5% and 5.5% in the current quarter. Beginning May 28, all passengers purchasing tickets will have to pay an as yet undefined fee for checked luggage.

Like most of its rivals, Southwest also pulled its financial outlook for the year, saying it would not reiterate its guidance for full-year 2025 or 2026 adjusted earnings.

Amid the current macroeconomic uncertainty, it is difficult to forecast given recent and short-lived booking trends, the airline said.

As tariffs hit air travel, airlines like Delta Air Lines and Frontier Airlines have pulled their full-year guidance, while United Airlines instead opted for the bold strategy of issuing dual forecasts (one for a recession and one for a normal year). American Airlines, which reported Thursday morning, opted to yank its guidance as well.

With investors fearing a tariff-y travel slump, the big four airlines, which collectively control 80% of the US market, have shed more than $32 billion in market cap so far this year as of Wednesdays close.

Southwest bag revenue - Chartr
Southwest is finally looking to cash in on customers checking bags. Passenger volume vs baggage revenue: Chartr

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.